ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,442Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 335

$1.05M Total Retail Price of All Prescriptions

Rank: 4 out of 335

1,671 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 1,671 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

0% of this provider’s 15,198 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
CLOPIDOGREL 1,484 1,060 10 1 7
SIMVASTATIN 1,240 950 2 4
FUROSEMIDE 1,141 838 3 6
AMLODIPINE BESYLATE 1,066 737 4 5
METOPROLOL TARTRATE 1,045 753 5 3
LISINOPRIL 982 647 6 2
ISOSORBIDE MONONITRATE ER 964 701 7 10
PLAVIX 933 680 8 12
WARFARIN SODIUM 924 685 9 8
POTASSIUM CHLORIDE 708 525 10 18
DIGOXIN 669 428 11 14
CARVEDILOL 658 461 12 1
HYDROCHLOROTHIAZIDE 640 491 13 19
NITROSTAT 386 241 14 22
RAMIPRIL 369 289 15 23
EFFIENT 290 159 16 37
OMEPRAZOLE 280 197 17 29
LOSARTAN POTASSIUM 269 199 18 16
FENOFIBRATE 248 193 19 47
ATORVASTATIN CALCIUM 241 169 20 11
RANEXA 241 149 20 25
BYSTOLIC 202 181 22 31
AMIODARONE HCL 194 148 23 21
CRESTOR 193 135 24 17
LOVASTATIN 187 137 25 49
NIASPAN 164 102 26 35
METOPROLOL SUCCINATE 162 116 27 9
SPIRONOLACTONE 161 92 28 20
DILTIAZEM 24HR CD 161 86 28 42
HYDROCODONE-ACETAMINOPHEN 153 104 S3 30 55
HYDRALAZINE HCL 147 118 31 26
DIOVAN 138 96 32 28
ATENOLOL 134 81 33 15
ZETIA 123 82 34 34
PRAVASTATIN SODIUM 121 91 35 13
KLOR-CON 10 112 85 36 60
PANTOPRAZOLE SODIUM 111 69 37 48
DILTIAZEM ER 109 69 38 56
LEVOFLOXACIN 108 88 39 114
FAMOTIDINE 107 79 40 65
TRICOR 101 71 41 74
MULTAQ 98 57 42 41
PRADAXA 97 82 43 32
DIOVAN HCT 96 58 44 81
CLONIDINE HCL 90 61 45 33
RANITIDINE HCL 90 54 45 83
AMLODIPINE BESYLATE-BENAZEPRIL 87 81 47 62
LOVAZA 82 54 48 78
GABAPENTIN 80 65 49 71
TRILIPIX 80 64 49 101
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 64 51 44
TRAMADOL HCL 75 43 52 82
LIPITOR 74 59 53 40
KLOR-CON M20 73 45 54 39
ZOLPIDEM TARTRATE 72 51 55 69
BENAZEPRIL HCL 67 49 56 30
NEXIUM 65 56 57 72
GEMFIBROZIL 63 33 58 91
PREDNISONE 61 45 59 100
LYRICA 60 40 60 177
XARELTO 60 45 60 84
ESCITALOPRAM OXALATE 55 50 62 107
ENALAPRIL MALEATE 54 19 63 38
VERAPAMIL HCL 53 27 64 150
VERAPAMIL ER 50 36 65 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.